Muñiz-Castrillo Sergio, Joubert Bastien, Elsensohn Mad-Hélénie, Pinto Anne-Laurie, Saint-Martin Margaux, Vogrig Alberto, Picard Géraldine, Rogemond Véronique, Dubois Valérie, Tamouza Ryad, Maucort-Boulch Delphine, Honnorat Jérôme
French National Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hôpital Neurologique, Hospices Civils de Lyon, Bron, France.
SynatAc Team, Institut NeuroMyoGène, INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1076-1084. doi: 10.1136/jnnp-2020-323226. Epub 2020 Jul 10.
Antibodies against contactin-associated protein-like 2 (CASPR2-Abs) have been described in acquired neuromyotonia, limbic encephalitis (LE) and Morvan syndrome (MoS). However, it is unknown whether these constitute one sole spectrum of diseases with the same immunopathogenesis or three distinct entities with different mechanisms.
A cluster analysis of neurological symptoms was performed in a retrospective cohort of 56 CASPR2-Abs patients. In parallel, immunological features and human leucocyte antigen (HLA) were studied.
Cluster analysis distinguished patients with predominant limbic symptoms (n=29/56) from those with peripheral nerve hyperexcitability (PNH; n=27/56). In the limbic-prominent group, limbic features were either isolated (LE/-; 18/56, 32.1%), or combined with extralimbic symptoms (LE/+; 11/56, 19.6%). Those with PNH were separated in one group with severe PNH and extralimbic involvement (PNH/+; 16/56, 28.6%), resembling historical MoS descriptions; and one group with milder and usually isolated PNH (PNH/-; 11/56, 19.6%). LE/- and LE/+ patients shared immunogenetic characteristics demonstrating a homogeneous entity. HLA-DRB111:01 was carried more frequently than in healthy controls only by patients with LE (94.1% vs 18.3%; p=1.3×10). Patients with LE also had serum titres (median 1:40 960) and rates of cerebrospinal fluid positivity (93.1%) higher than the other groups (p<0.05). Conversely, DRB111:01 association was absent in PNH/+ patients, but only they had malignant thymoma (87.5%), serum antibodies against leucine-rich glioma-inactivated 1 protein (66.7%) and against netrin-1 receptor deleted in colorectal carcinoma (53.8%), and myasthenia gravis (50.0%).
Symptoms' distribution supports specific clinical phenotypes without overlap between LE and MoS. The distinct immunogenetic characteristics shared by all patients with LE and the particular oncological and autoimmune associations of MoS suggest two very different aetiopathogenesis.
在获得性神经性肌强直、边缘叶脑炎(LE)和莫旺综合征(MoS)中已发现抗接触蛋白相关蛋白样2抗体(CASPR2 - Abs)。然而,尚不清楚这些疾病是具有相同免疫发病机制的单一疾病谱,还是具有不同机制的三种不同实体。
对56例CASPR2 - Abs患者的回顾性队列进行神经症状的聚类分析。同时,研究免疫特征和人类白细胞抗原(HLA)。
聚类分析将以边缘叶症状为主的患者(n = 29/56)与周围神经兴奋性增高(PNH;n = 27/56)的患者区分开来。在以边缘叶症状为主的组中,边缘叶特征要么是孤立的(LE/-;18/56,32.1%),要么与边缘叶外症状合并(LE/+;11/56,19.6%)。PNH患者分为一组,具有严重PNH和边缘叶外受累(PNH/+;16/56,28.6%),类似于历史上对MoS的描述;另一组为较轻且通常孤立的PNH(PNH/-;11/56,19.6%)。LE/-和LE/+患者具有共同的免疫遗传特征,表明是一个同质实体。仅LE患者携带HLA - DRB111:01的频率高于健康对照(94.1%对18.3%;p = 1.3×10)。LE患者的血清滴度(中位数1:40 960)和脑脊液阳性率(93.1%)也高于其他组(p<0.05)。相反,PNH/+患者不存在DRB111:01关联,但只有他们患有恶性胸腺瘤(87.5%)、抗富含亮氨酸胶质瘤失活1蛋白的血清抗体(66.7%)和抗结直肠癌缺失的netrin - 1受体的血清抗体(53.8%)以及重症肌无力(50.0%)。
症状分布支持LE和MoS之间无重叠的特定临床表型。所有LE患者共有的独特免疫遗传特征以及MoS的特定肿瘤学和自身免疫关联提示两种截然不同的病因发病机制。